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Background: Hyperleptinemia is known to participate in cardiac hypertrophy and hypertension, but the
relationship between pressure overload and leptin is poorly understood. We therefore examined the expression of
leptin (ob) and the leptin receptor (ob-R) in the pressure-overloaded rat heart. We also examined gene expressions
in culture cardiac myocytes to clarify which hypertension-related stimulus induces these genes.
Results: Pressure overload was produced by ligation of the rat abdominal aorta, and ob and ob-R isoform mRNAs
were measured using a real-time polymerase chain reaction (PCR). We also measured these gene expressions in
neonatal rat cardiac myocytes treated with angiotensin II (ANGII), endothelin-1 (ET-1), or cyclic mechanical stretch.
Leptin and the long form of the leptin receptor (ob-Rb) gene were significantly increased 4 weeks after banding,
but expression of the short form of the leptin receptor (ob-Ra) was unchanged. ob-Rb protein expression was also
detected by immunohistochemistry in hypertrophied cardiac myocytes after banding. Meanwhile, plasma leptin
concentrations were not different between the control and banding groups. In cultured myocytes, ANGII and ET-1
increased only ob mRNA expression. However, mechanical stretch activated both ob and ob-Rb mRNA expression
in a time-dependent manner, but ob-Ra mRNA was unchanged by any stress.
Conclusions: We first demonstrated that both pressure mediated hypertrophy and mechanical stretch up-regulate
ob-Rb gene expression in heart and cardiac myocytes, which are thought to be important for leptin action in
cardiac myocytes. These results suggest a new local mechanism by which leptin affects cardiac remodeling in
pressure-overloaded hearts.
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Leptin, the product of the ob gene [1], was discovered ori-
ginally as an adipocyte-derived cytokine that acts in the
hypothalamus to regulate appetite and energy expenditure
[2]. In spite of its anti-obese effects, serum leptin concen-
trations are correlated strongly with body mass index, and
obesity is associated with hyperleptinemia [3,4]. Leptin is
also known to have pleiotropic effects on many peripheral
tissues [5]. In the cardiovascular system, hyperleptinemia
has been linked to left ventricular mass in severe obese* Correspondence: tyokoyama@gunma-u.ac.jp
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reproduction in any medium, provided the orpatients [6], elevated serum leptin concentrations are
found in patients with congestive heart failure [7],
and leptin has been identified as a risk factor for
myocardial infarction [8]. Experimental data from ani-
mal studies and cultured myocytes indicate that leptin
directly induces hypertrophy in cardiac myocytes [9-12].
However, another experimental study showed that leptin
did not induce changes in size of rat neonatal cardiac
myocytes [13]. Thus, the cardiac effects of leptin are not
completely understood.
Myocardial hypertrophy is induced by various stimuli
in vivo, such as pressure or volume overload [14,15].
Thus, an investigation of molecular mechanisms inducing
cardiac hypertrophy in the setting of pressure overload isLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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dial remodeling. With respect to leptin and myocardial
remodeling, serum leptin concentrations are significantly
associated with myocardial wall thickness in hypertensive
men [16]. However, the relationship between pressure
overload and leptin in cardiac myocytes has not been
determined.
Moreover, leptin synthesis occurs in a variety of non-
adipose cells and leptin receptors are distributed in
many other tissues [17,18]. At least six alternatively
spliced isoforms of the leptin receptor (ob-Ra to ob-Rf )
have been identified in mice [19]. These include one
long receptor protein (ob-Rb) and five shorter receptor
proteins (ob-Ra, -Rc, -Rd, -Re, -Rf ). The long form of
the leptin receptor (ob-Rb) is similar to gp130, and acts
primarily through activation of the Janus kinase (JAK)
family of cytoplasmic tyrosine kinases, which in turn
activate transcription factors of the signal transduction
and activation of transcription (STAT) family [20].
We previously demonstrated that ischemia/reperfusion
induces leptin and leptin receptor mRNA and protein
expression in rat hearts, and treatment with an anti-
leptin antibody prevents the increase of tumor necrosis
factor-α (TNF-α) and interleukin-1β mRNA expression
in ischemic hearts [21]. These studies suggest that not
only increased serum leptin concentrations, but also
local leptin production and up-regulation of leptin
receptors may play an important role in leptin action in
heart disease.
In this study, we examined induction of leptin and
leptin receptor mRNA and protein expression in rat
hearts after pressure overload. Furthermore, to clarify
which hypertension-related stress activates leptin and
leptin receptor expression, we measured leptin and lep-
tin receptor mRNA expression in isolated ventricular
myocytes stimulated with angiotensin-II (ANGII),
endothelin-1 (ET-1), or mechanical stretch.
Methods
Animals and treatments
Thirty-five adult male Wistar rats (210 to 350 g) were
submitted to experiments, whereas 18 animals were used
as control groups (2 weeks; n=11, 4 weeks; n=7). In the
pressure-overloaded groups, invasive hemodynamic
measurements were performed 2 weeks (n=9) and
4 weeks (n=8) after banding. Cardiac hypertrophy was
produced using techniques as previously described [22].
Briefly, rats were anesthetized with sodium pentobarbital
(50 mg/kg, i.p.), and the suprarenal area of the descend-
ing aorta was isolated through a midline laparotomy.
Then, abdominal aortic constriction surgery was per-
formed by placing a constricting silver clip (21-gauge, in-
side diameter: 0.80 mm, or 22-gauge, inside diameter:
0.90 mm) around the abdominal aorta between the renaland superior mesenteric arteries. Sham-operated con-
trols underwent the same procedure except for the
placement of the aortic clip. All animals were housed
according to institutional guidelines for 4 weeks in cli-
mate controlled metabolic cages with a 12-hr light/12-hr
dark cycle, and food and water provided ad libitum. All
experiments using these rats were approved by and per-
formed according to the guidelines of the Animal Ethics
Committee of Gunma University, Maebashi, Japan
(Permit Number: 50153). Animals were allowed to re-
cover for 2 to 4 weeks, and body weight averaged 309 g
at 2 weeks and 324 g at 4 weeks in control rats, and
272 g at 2 weeks and 332 g at 4 weeks after banding.
Hemodynamic measurements and echocardiographic
evaluation
Pre-surgical rat blood pressure was measured using the
tail-cuff technique (LE 5001 Pressure Meter; Letica SA,
Barcelona, Spain). Rats were fasted for 16 hr prior to in-
vasive hemodynamic measurements and blood sampling.
Measurements of ascending aortic pressure and heart
rate were measured in an unrestricted, conscious state
through a heparinized indwelling polyethylene catheter
that was introduced into the left carotid artery 1 day
before measurement. Data were analyzed using Power
Lab and Chart v5.0.1 (AD Instrument: Castle Hill,
Australia). Blood was collected after hemodynamic mea-
surements and blood plasma was separated immediately
by centrifuging at 1500 g for 20 min at 4°C.
The degree of cardiac hypertrophy and left ventricular
function was measured by echocardiography (EUB6000,
Hitachi, Tokyo, Japan) using a 10-MHz probe. Before
surgery and 14 or 28 days after surgery, rats were
anesthetized with ketamine (50 mg/kg) and xylamine
(10 mg/kg) injected intraperitoneally and subjected to
echocardiographic study. LV mass, LV ejection fraction,
and the ratio of the early to late filling wave (E/A) of the
transmitral pulse-wave Doppler velocity were measured
as described previously.
Tissue preparation and total RNA extraction
Following induction of deep anesthesia, rats were killed
and the hearts were excised immediately. The atria and
right ventricle were removed, and the left ventricle was
weighed. The degree of hypertrophy was calculated in
each constricted and sham-operated rat using the ratio of
left-ventricular weight (LVW) to body weight (BW). After
their removal, left ventricles were frozen rapidly in liquid
nitrogen and stored at −70°C until real-time quantitative
RT-PCR analysis was performed. In addition, tissue blocks
from hearts were fixed in 4% paraformaldehyde for 4 to
12 hr, embedded in paraffin, and sectioned at a thickness
of 4-μm for immunohistochemistry. For each animal, we
also measured the diameter of 10 cardiac myocytes chosen
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and eosin (HE).
Real-time quantitative RT-PCR
Total RNA was extracted from hearts using Isogen
reagent (Nippon Gene, Tokyo, Japan) as described by the
manufacturer’s protocol. cDNA was synthesized from
2 μg of mRNA with an RNA PCR kit (Takara, Tokyo,
Japan) using an oligo-dT primer. Reaction mixtures were
incubated for 30 min at 42°C, 5 min at 99°C, and 5 min at
5°C. SYBR Green quantitative PCR assays were performed
using a MX3000P Multiplex Quantitative PCR System
((Agilent Technologies, Palo Alto, CA) and Brilliant SYBR
Green QPCR Master Mix kit (Agilent Technologies).
Primer sequences used to amplify various cDNAs are
shown in Table 1. A typical PCR protocol was performed
under the following conditions: 10 min at 95°C, followed
by a total of 50 three-temperature cycles (95°C
denaturation for 30 sec, annealing temperature for 1 min,
and a 72°C extension for 1 min). Specificity of the SYBR
Green amplicons was confirmed by melting point analysis
and gel electrophoresis in the presence of ethidium brom-
ide (Nippon Gene, Tokyo, Japan). Expression of the
housekeeping gene GAPDH was used for normalization.
All quantitative PCR assay data for ob, ob-Ra, and ob-Rb
mRNA was normalized by GAPDH mRNA of the
same sample, and expressed as a relative amount to
the control group.
Immunohistochemistry
Immunohistochemical staining was performed using a
DAKO Catalyzed Signal Amplification (CSA) system
(DAKO, Carpinteria, CA), according to the manufac-
turer’s instructions. Tissue cross sections (4-μm) includ-
ing the left ventricle and interventricular septum were
stained with rabbit polyclonal anti-ob-Rb (OBR13-A)
antibody (Alpha Diagnostics, San Antonio, TX) at dilu-
tions of 1:150 in Tris-buffered saline (TBS) for 15 min at
room temperature. Counterstaining was done with 2%










Ob: leptin, ob-Ra –Rb; leptin receptor isoforms.control, while negative controls were produced by
substituting nonimmune mouse immunoglobulin (DAKO)
for the primary antibody.
To determine ob-Rb protein expression semi-quantita-
tively, we evaluated the percentage of area staining posi-
tive relative to the total area from 12 randomly chosen
fields in left ventricles using Image J photographic
software (National Institutes of Health).
Western blot analyses
Whole heart extracts were prepared using modified RIPA
buffer containing 50 mM Tris–HCl (pH7.4), 150 mM
NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate,
1 mM EDTA, and containing complete mini and phos-
STOP solution (Roche Diagnostics, Tokyo, Japan). The
mixture was rotated at 4°C for 15 min and centrifuged at
14,000 rpm for 15 min. Western blot analysis was
performed according to standard procedures using the
following primary antibodies: polyclonal leptin (PA1-051;
Thermo Scientific, Rockford, IL), mouse monoclonal
anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(MAB374; Millipore, Billerica, MA), rabbit monoclonal
phospho-STAT3 [Tyr705] (#9145) and STAT3 (#4904)
mAb (Cell Signaling, Tokyo, Japan). Antigens were
revealed by Immobilon Western Chemiluminescent HRP
Substrate (Millipore, Bedford, MA) after incubation with
horseradish peroxidase-conjugated anti-rabbit IgG.
For quantitative analysis, western blot analysis data for
phospho-STAT3 was normalized by total STAT3 protein
of the same sample using Image J photographic soft ware,
and the STAT3 activity of banding group was expressed as
a relative amount to control group in respective time.
Measurements of plasma leptin concentrations
Rat blood was collected from the ascending aorta and
plasma concentrations of leptin were evaluated using a
leptin rat ELISA system (Amersham Pharmacia Biotech,
Piscataway, NJ), according to the manufacturer’s instruc-
tions. The optical densities of the ELISA samples were
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Chantillly, VA).Preparation of neonatal rat cardiac myocytes
Primary neonatal rat cardiac myocyte cultures were
prepared as previously described [23]. Cardiac myocytes
were plated 2.5 × 106 cells in 60-mm culture dishes, and
2 × 105 cells per well for mechanical stretch. Using this
method, we routinely obtained cardiac myocyte-rich
cultures with >95% of the cells being cardiac myocytes,
as assessed by immunocytochemical staining with mono-
clonal antibodies against sarcomeric α-actinin (Sigma
Chemical Co., St. Louis, MO).Mechanical stretch and humoral factor stimulation of
cardiac myocytes
Cyclic mechanical stretch was performed in vitro using a
Flexcell strain unit (Flexcell International, McKeesport,
PA). Cardiac myocytes were cultured in six-well plates
with flexible gelatin-coated silicone rubber membranes at
the bottom of each well. A vacuum (~28 kPa) was applied
at a frequency of 6 cycles/min (4-sec on time, 6-sec off
time) to the flexible membrane from the base of the plate.
The maximal percent elongation of the culture surface
was 18%. Previously, we reported that this protocol was
sufficient to demonstrate cellular responses in stretched
myocytes [23]. Following 1 to 24 hr of mechanical stretch,
cells were collected with phosphate-buffered saline (PBS;
pH 7.4) with 1% EDTA.
Serum-starved (24 hr) cardiac myocytes were incubated
in the presence or absence of angiotensin-II (ANGII: 1 to
10 μM) or endothelin-1 (ET-1: 0.01 to 0.1 μM). After
24 hr of incubation at 37°C, mRNA was collected from
the cells.
We previously showed using the same neonatal rat
cardiac myocyte cultures that 0.1 μM of ET-1 increased
cell size and expression of atrial natriuretic factor m-RNA
[24], and stimulation with cyclic mechanical stretch for
6 hr increased phenylalanine incorporation in cardiac
myocytes 40.8% higher than that in control cells [23].
Thus, we used this in vitro model for the model of cardiac
myocyte hypertrophy.Statistical analysis
Values are reported as the mean ± SD. To compare the
value at 2 or 4 weeks after banding to the control value
at each period, we used student t test for analysis. To
evaluate differences between multi-groups, we used one
way ANOVA. Where appropriate, post hoc multiple
comparison tests were performed to evaluate differences
between the control and experimental groups. A p value
<0.05 was considered significant.Results
Cardiac structure and function in pressure-overloaded rat
hearts
To assess for evidence of cardiac hypertrophy, cardiac
functional parameters were carefully monitored. Systolic
and diastolic pressures measured by catheter implanted
into carotid artery in the pressure-overloaded group were
significantly elevated over the control group at 2 weeks
after banding, and systolic but not diastolic pressure was
increased in the pressure-overloaded group at 4 weeks
after banding (Figure 1A and B). There were no differ-
ences in presurgical BW between the two groups.
Although the LVW was significantly increased in the
4 weeks pressure-overloaded group but not in the 2 weeks
banding, the LVW/BW ratios in the 2 and 4 weeks
pressure-overloaded groups were significantly higher than
those of the respective control groups (Figure 1C and D).
We also measured the diameter of cardiac myocytes in
the left ventricular sections with HE staining. The mean
diameters in the pressure-overloaded groups were signifi-
cantly higher than those of the respective control groups
(Figure 1E). Furthermore, M-mode echocardiography
demonstrated concentric LV hypertrophy, while the
ejection fraction was similar to that in control rats
(Figure 1F). In pressure-overloaded rats, transmitral Dop-
pler velocity showed decreased early and increased late
filling velocities, resulting in a reduced E/A compared with
control rats, although the difference was not significant
(Figure 1G). These data indicate the induction of cardiac
hypertrophy without the development of congestive heart
failure in the experimental group.
mRNA expression of ob and ob-R isoforms in pressure-
overloaded hearts
In normal rat hearts, both ob and ob-R mRNA expres-
sion were detectable by RT-PCR (Figure 2A). Among the
ob-R isoforms, mRNA for the ob-Ra isoform was
expressed at a high level, whereas ob-Rb expression was
detected at lower levels than ob-Ra expression. To deter-
mine the effects of pressure-overload on the expression
of ob and ob-R isoforms in rat hearts, ob and ob-R
mRNA expression was determined using real-time
quantitative RT-PCR 2 weeks or 4 weeks after surgery.
As shown in Figure 2 B and D, ob mRNA increased sig-
nificantly at 4 weeks and ob-Rb mRNA increased signifi-
cantly at 2 and 4 weeks after aortic banding (ob/GAPDH,
2w: 2.2±2.3 fold, 4w: 2.7±1.6 fold*, ob-Rb/GAPDH, 2w:
1.6±0.5 fold*; 4w: 1.9±0.7 fold* relative to control,
*p<0.05). On the other hand, there was big individual
difference in the ob gene expression every animal at
2 weeks after banding, and no significant difference
was shown compared to control group. At the same
time, ob-Ra mRNA expression did not change between
the two groups (Figure 2C).
Figure 1 Cardiac structure and function in pressure-overloaded rat hearts. Blood pressure in the control group and the pressure-overloaded
group (A), (B); systolic blood pressure (A) and diastolic blood pressure (B), pre: n=11, 2w: control n=6, banding n=4, 4w: control n=4, banding
n=5. LV mass (C), heart/body weight ratio (D) and mean diameters of left ventricular cardiac myocytes (E) in the control group and the pressure-
overloaded group, 2w: control n=11, banding n=9, 4w: control n=7, banding n=8. Echocardiographic evaluation of left ventricular function (F),
(G). Ejection fraction (F) and the transmitral E/A ratio (G), pre: n=13, 2w: control n=5, banding n=7, 4w: control n=5, banding n=5. Values are
reported as means ± SD. *p<0.05, **p<0.01 vs. control.
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Figure 2 mRNA expression of ob and ob-R isoforms in
pressure-overloaded hearts. mRNA expression of the ob and ob-R
isoforms in the normal rat heart (A). mRNA levels of ob (B), ob-Ra
(C), and ob-Rb (D) isoforms in pressure-overloaded rat hearts. All
quantitative PCR assay data for ob, ob-Ra, and ob-Rb mRNA is
normalized by GAPDH mRNA of the same sample, and expressed as
fold increase compared with the mean level of control groups at 2
or 4 weeks after surgery. 2w: control n=11, banding n=9, 4w: control
n=7, banding n=8. Values are reported as means ± SD. *p<0.05 vs.
control.
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overloaded hearts
To determine the expression of ob-Rb proteins in hyper-
trophic hearts, we performed immunohistochemical
staining in ventricular sections with anti-ob-Rb anti-
bodies 2 and 4 weeks after aortic constriction. Although
minimal ob-Rb staining was observed in the control
hearts (Figure 3A), the area of ob-Rb positively staining
was significantly increased in the pressure-overloaded
group after 2 and 4 weeks (Figure 3C and E and Table 2).
When we observed the detailed location of ob-Rb
positive staining area, with HE staining as a guide
(Figure 3D and F), ob-Rb was expressed in cytoplasmic
membranes of hypertrophic cardiac myocytes, but not in
normal cardiac myocytes or non-myocytes.
STAT3 activity in pressure-overloaded hearts
As shown in Figure 4A and B, the content of phosphory-
lated STAT3 in control rat hearts at 2 weeks after sham
operation was stronger than that at 4 weeks later and
the content of phosphorylated STAT3 was increased in
rat hearts after banding compared to that in control rats.
The relative amount of phosphorylated STAT3 to
respective control group was significantly increased in
rat hearts at 2 and 4 weeks after banding. Thus pressure
overload induced STAT3 activity in the heart.Figure 3 Localization of ob-Rb protein expression in pressure-
overloaded hearts. Immunohistochemical staining for ob-Rb
protein (A, C, and E) and corresponding HE-stained sections (B, D,
and F) of rat myocardium after aortic constriction. (A), (B): control
heart; (C), (D): 2-week pressure-overloaded rat heart, and (E), (F):
4-week pressure-overloaded rat heart. Original magnification, x400
for (A) through (F). Bar=0.05 mm. Counterstaining was done with
2% methyl green.
Table 2 Semi-quantification of ob-Rb protein expression
Control Banding
2-week 0.057 ± 0.094 0.181 ± 0.113*
(n=11) (n=9)
4-week 0.028 ± 0.021 0.103 ± 0.058*
(n=7) (n=8)
Values are percentage of area staining positive relative to the total area in the
left ventricles (mean ± SD). *: p<0.05 vs. control.
Figure 5 Leptin protein level in pressure-overloaded hearts.
Leptin protein level in the control rat hearts (control) and pressure-
loaded rat hearts (banding) at 4 weeks after surgery. Leptin content
in hearts was determined with Western blot analysis. GAPDH was
measured as an internal control. n=2 in each group.
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To determine the leptin protein level in hypertrophic
hearts, we performed Western blot analysis. The tissue
leptin protein level in rat heart was increased in 4 weeks
after banding compared to relative control (Figure 5).Plasma leptin concentrations in pressure-overloaded and
sham-operated groups
To determine whether hypertensive stress modulates the
plasma leptin concentration of pressure-overloaded rats,
we performed rat leptin ELISA assays. However, we
could not show differences between the control and
banding groups (Table 3).Figure 4 STAT3 activity in pressure-overloaded hearts. STAT3
activity in the control rat hearts (control) and pressure-loaded rat
hearts (banding) at 2 and 4 weeks after surgery (A). Phosphorylated
STAT3 content (p-STAT3) and total STAT3 content (STAT3) in hearts
were determined with Western blot analysis. Western blot data for
p-STAT3 is normalized by total STAT3 of the same sample, and
expressed fold increase compared with mean level of control group
(B). 2w: control n=3, banding n=5, 4w: control n=3, banding n=3.
Values are reported as means ± SD. *p<0.05 vs. control.Effect of ANG-II, ET-1, and cyclic mechanical stretch in
cardiac myocytes
On the basis of the above observations, we concluded
that ob and ob-Rb are induced by pressure-overload
stress in cardiac myocytes. Therefore, additional experi-
ments were performed using cardiac myocyte cultures to
clarify which hypertensive stresses, including mechanical
stretch and neurohumoral factors, increase ob and ob-
Rb expression. Therefore, we examined mRNA expres-
sion in neonatal rat cardiac myocytes treated with
ANGII (1 to 10 μM), ET-1 (0.01 to 0.1 μM), or cyclic
mechanical stretch. ANGII and ET-1 stimulated ob
mRNA expression (1 μM ANGII: 1.7 ± 0.4 fold*,
0.01 μM ET-1: 1.7 ± 0.5 fold* relative to control,
*p<0.05), but ob-Ra and ob-Rb expression were un-
changed by ANGII. Further ob-Rb expression was
reduced, and ob-Ra expression was unchanged by ET-1
(Figure 6). In contrast, mechanical stretch induced ob
and ob-Rb mRNA expression in a time-dependent
manner (ob/GAPDH: 2.0 ± 0.5 fold*, ob-Rb/GAPDH:
2.2 ± 0.3 fold* relative to control, *p<0.05). However, ob-
Ra was also unchanged by mechanical stretch (Figure 7).
Discussion
With respect to leptin and cardiac hypertrophy, clinical
investigations have demonstrated that fasting plasma lep-
tin concentrations are associated with increased myocar-
dial wall thickness independent of body weight and blood
pressure in hypertensive men [16]. Many researchers haveTable 3 Plasma leptin concentration
Control Banding
2-week 3.62 ± 2.11 3.40 ± 2.54
(n=7) (n=4)
4-week 3.89 ± 1.82 3.22 ± 1.41
(n=4) (n=5)
Values are mean ± SD (ng/ml).
Figure 6 Effect of ANG-II and ET-1 in cardiac myocytes. Effect of
neurohumoral factors on ob, ob-Ra, and ob-Rb mRNA expression in
neonatal rat cardiac myocytes. Neonatal rat cardiac myocytes were
treated with ANGII (1 to 10 μM), ET-1 (0.01 to 0.1 μM) for 24 h. All
quantitative PCR assay data for ob, ob-Ra, and ob-Rb mRNA is
normalized by GAPDH mRNA of the same sample, and expressed as
fold increase compared with the mean level of control dishes. n=4
dishes in each group. Values are reported as means ± SD. *p<0.05
vs. control.
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induces hypertrophy in cultured neonatal rat ventricular
myocytes [9-12], and the hypertrophic effects of leptin
were prevented by antibodies to ob-Ra and ob-Rb [25].
The direct effects of leptin for cardiac function in which
administration of leptin to adult rat ventricular myocytes
attenuated cardiac contraction were also observed [26].
Although systolic and diastolic cardiac function para-
meters measured by M-mode echocardiography at 2 or
4 weeks after pressure overload were not decreased in ourFigure 7 Effect of cyclic mechanical stretch in cardiac
myocytes. Effect of cyclic mechanical stretch on ob, ob-Ra,
and ob-Rb mRNA expression in neonatal rat cardiac myocytes.
Neonatal rat cardiac myocytes were treated with mechanical stretch
for 1 to 24 h. All quantitative PCR assay data for ob, ob-Ra, and
ob-Rb mRNA is normalized by GAPDH mRNA of the same sample,
and expressed as fold increase compared with the mean level of
control wells. n=4 dishes in each group. Values are reported as
means ± SD. *p<0.05 vs. control.study, 2 month-lasting pressure-overloaded model showed
a worsening of LV contraction [27]. Thus, 4 weeks of
pressure overload can induce cardiac hypertrophy, but
may be not enough to reduce cardiac function.
On the other hand, recent studies in mice demon-
strated the anti-hypertrophic effect of leptin in which
the blunting leptin signaling through a leptin-deficiency
or leptin receptor-deficiency is associated with progres-
sive ventricular hypertrophy in these obese mice [28,29].
In addition, a cardiac myocyte-specific reduction of ob-R
expression in mice results in worse cardiac hypertrophy
and function after experimental myocardial infarction
[30]. With respect to pressure overload hypertrophy, left
ventricular mass in leptin deficient mice subjected to
transverse aortic constriction was significantly higher
than in wild type mice [31]. Furthermore, a recent study
shows that low serum leptin levels are associated with
increased cardiovascular events and mortality in patients
with stable coronary artery disease [32]. This prospective
cohort study suggests the protective effect of leptin for
heart disease. Thus, the role of leptin on heart disease is
still controversial both in experimental and human studies.
Although the direct effects of leptin on the progression of
cardiac hypertrophy are still controversial and is compli-
cated, as mentioned in above, the local induction of leptin
and/or leptin receptor expression on cardiac myocytes
should be important to the progression of cardiovascular
diseases, even if leptin has an anti-hypertrophic effect.
Our study demonstrates that ob gene mRNA can be
detected in rat hearts by real-time PCR. Furthermore,
the expression of ob mRNA and the leptin protein level
in the heart increased 4 weeks after aortic banding. Since
circulating plasma leptin concentrations were not differ-
ent between control and pressure-overloaded rats, the
local production of leptin could be important for the
action of leptin on cardiac myocytes. The relationship
between plasma leptin concentrations and blood pres-
sure in animal models and in humans has been investi-
gated [33-35]. However, most of these studies found that
the positive relationship between leptin and blood
pressure is dependent on total fat mass [36,37]. Thus,
whether high blood pressure without obesity stimulates
leptin synthesis in adipocytes and/or other types of cells
is not known. In this study, heart ob gene expression
was increased 4 weeks after banding, but this increase
was not parallel with the increase of systolic or diastolic
blood pressure. Thus, some humoral factor associated
with pressure overload, e.g. ANGII or ET-1, may involve
the up-regulation of leptin gene.
In cultured cardiac myocytes, many stimuli induce car-
diac hypertrophy, including mechanical stretch, ANGII,
and ET-1. To clarify which hypertension-related stimu-
lus induces ob and ob-R mRNA expression in cardiac
myocytes, we examined their mRNA expressions in
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ET-1, or cyclic mechanical stretch. All three stimuli
increased the expression of ob mRNA, but ob-Rb mRNA
only increased with mechanical stretch and ob-Ra
mRNA was unaffected by any stimulus. These results,
together with the increased expression of ob and ob-Rb
mRNA in hearts after aortic banding, strongly suggest
that leptin affects cardiac myocytes during pressure
overload in a local manner. Recently, similar results were
reported using other types of cells in which stretch acti-
vated ob and ob-Rb expression in a cultured rat portal
vein [38]. Moreover, ANGII and ET-1 promote leptin
production in cultured adipocytes and neonatal rat ven-
tricular myocytes [25,39]. Although we showed that ob
mRNA expression was induced by both mechanical
stretch and humoral factors, neither ANGII or ET-1 up-
regulated ob-Ra and ob-Rb mRNA expression in neo-
natal rat cultured cardiac myocytes, Thus mechanical
stretch is the most important stimulation for ob-Rb gene
induction in our study. However, Rajapurohitam et al.
[25] showed that both ANGII and ET-1 stimulated the
gene expression of ob-Ra and ob-Rb using similar cul-
tured cardiac myocytes. The exact reason for the dis-
crepancy between our results and this study is not
known. The different conditions of cell culture may lead
to different responses to ANGII and ET-1.
The murine leptin receptor exists in six isoforms formed
by alternative splicing [40]. All isoforms have the same
extracellular domain, and ob-Ra, -Rc, -Rd, and -Rf contain
short intracellular domains, whereas only ob-Rb has a
long cytoplasmic domain [41]. De Matteris et al. [42] stud-
ied localization of leptin receptor isoforms in mouse per-
ipheral tissues by immunohistochemistry. Their results
indicate that most of the organs studied expressed ob-Ra,
including the heart, and also expressed ob-Rb, although
staining for ob-Rb was weaker. Using real-time PCR, at
least three of the leptin receptor isoforms, including ob-
Ra, ob-Rb, and ob-Re, can be detected in adult rat hearts
[43]. Moreover, long and short isoforms of the leptin re-
ceptor and intracellular proteins mediating leptin signal-
ing are expressed in human hearts based on real-time
PCR and immunohistochemistry [6]. We demonstrated by
the real-time PCR that both short and long forms of the
leptin receptors are expressed in rat hearts as well as neo-
natal rat ventricular myocytes. Expression of ob-Rb was
weaker than that of ob-Ra in rat hearts, in keeping with
previous reports. However, ob-Rb mRNA and protein ex-
pression were significantly increased 2 to 4 weeks after
aortic banding in comparison with control rats, whereas
ob-Ra expression was unchanged. Unlike ob-Rb, ob-Ra is
continuously expressed in hearts. We first showed that
pressure overload and mechanical stretch induce ob-Rb,
but not ob-Ra in cardiac myocytes both in in vivo and
in vitro models. These results emphasize the role of thelong form leptin receptor in leptin-associated heart
disease. On the other hand, both ob-Ra and ob-Rb genes
and protein expressions were increased in spontaneously
hypertensive rat vascular smooth muscle cells [44]. Regu-
lation of leptin receptor expression may be different de-
pending on tissue or cell types.
The long form of the leptin receptor (ob-Rb) activates
JAK/STAT pathways, and ob-Rb activation also may
phosphorylate JAK leading to the activation of insulin
receptor substrate (IRS-1) and mitogen-activated protein
kinase (MAPK). The short form of the leptin receptor
(ob-Ra) phosphorylates IRS-1 and consequently activates
MAPK, but appears to be unable to activate the JAK/
STAT pathway [5,45]. Mice lacking only the ob-Rb, but
not the ob-Ra gene have an indistinguishable pheno-
type from all leptin receptor deficient mice [4,19].
Thus, ob-Rb and the ob-Rb activating JAK/STAT path-
ways are crucial for leptin action. Several experiments
have shown that leptin stimulates various intracellular
signaling cascades in cardiac myocytes, including JAK/
STAT, extracellular signal-regulated kinase (ERK)1/2, p38
MAPK, RhoA/Rho kinase (ROCK) system, reactive oxy-
gen species, and nitric oxide pathways (reviewed by
Karmazyn et al. [46]).
Rajapurohitan et al. [9] demonstrated that the hyper-
trophic effects of leptin were inhibited by a p38 MAPK
inhibitor, and they identified only ob-Ra mRNA in neo-
natal rat cardiac myocytes. In contrast to this previous
study, our results demonstrate that both ob-Ra and ob-
Rb mRNA are present in isolated neonatal rat ventricu-
lar myocytes as well as adult rat hearts, and mechanical
stretch activates ob-Rb mRNA expression in cardiac
myocytes. Although leptin mediated hypertrophy, at
least in part through a p38 MAPK pathway [11,47], ob-
Rb, but not ob-Ra, activates the JAK/STAT pathway, and
has a prominent role in leptin signaling. Abe et al. [12]
demonstrated that leptin induces cardiac myocyte elong-
ation via the JAK/STAT pathway, but not through the
MAPK pathway. A recent study using ob-Rb deficient
db/db mouse showed that leptin induced inflammatory
response of adipose tissue amplified through ob-Ra
when ob-Rb is defective [48]. Ob-Ra may transmit leptin
signal to cardiac myocytes independently from pressure
over load or mechanical stretch.
Meanwhile, McGaffin et al. [30] demonstrated that in-
tact cardiac leptin signaling in ischemic heart failure is
important for the maintenance of glycolytic metabolism,
involves the activation of STAT3, and attenuates adverse
cardiac remodeling post myocardial infarction. Mice
with cardiac myocyte-specific overexpression of STAT3
present increased capillary density and develop a con-
centric hypertrophy with preserved cardiac function
[49]. Furthermore, mice with the gp130 gene, an up-
stream component of STAT3, knocked out in cardiac-
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pressure overload [50]. Despite the induction of cardiac
hypertrophy by activation of JAK/STAT signaling, STAT3
plays a key role in cardio-protection in response to
numerous stress situations including pressure overload.
Although we did not intend to show the direct effect of
ob-Rb to the JAK/STAT pathway in this study, pressure
overload induced STAT3 activity in the heart. The
increased number of leptin attached to the long form
leptin receptor in cardiac myocytes under pressure
overload and mechanical stretch may activate STAT3 and
result in the cardio-protective effect of leptin.
Conclusions
Adipocytokines including leptin have now attracted more
attention due to their distinct effects in the cardiovascular
system and their predictive values for future cardiaovascu-
lar events, especially in obese subjects [51]. In this study,
we first demonstrated that both pressure mediated hyper-
trophy and mechanical stretch up-regulate the long form
of the leptin receptor gene expression in heart and cardiac
myocytes, which is thought to be important for leptin
action in cardiac myocytes. Although previous reports are
divided on whether leptin has predominantly adverse or
beneficial effects on cardiac hypertrophy, our results
suggest a new local mechanism by which leptin directly
affects cardiac remodeling in pressure-overloaded hearts.
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